Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by rags2ragson Apr 20, 2023 11:44am
162 Views
Post# 35405367

Globe Today

Globe Today
jxfzsy/iStockPhoto / Getty Images
Your doctor is about to be automated and these companies will benefit
Citi analyst Adam Spielman believes that health care will become increasingly automated by artificial intelligence in the coming years. The market for AI-assisted diagnostic tools is expected to quadruple to US$4-billion in the next four years, benefiting a wide variety of companies including Microsoft Co., NVIDIA Corp. and the health care division of General Electric Co.
AI has been more accurate than human radiologists for a decade, according to Citi, and is challenging doctors’ skills in oncology and stroke recognition. The potential for AI in medical fields is vast. Microsoft, for instance, just paid US$20-billion for a company called Nuance that listens to doctor patient conversations and immediately creates clinical notes. Also, NVIDIA is developing AI that can analyze the function of protein molecules and DNA.
The proliferation of AI in health care faces opposition from doctors who fear being replaced and also patients. The British Association of Dermatologists is fighting the implementation of an AI-based triage tool. Also, a Pew Research survey found that 79 per cent of those surveyed did not want AI involved in mental health.
But it is also the case that wearable technology is expected to provide a gateway to AI acceptance in medical care by eventually providing functions like blood sugar measurement. Those concerned about racial bias in treatment are also likely to support more automation.
Investors can expect the adoption of AI health care as a longer-term trend that will burn slowly. There’s no hurry to get exposure to the theme but investors should be on the lookout for opportunities in the coming years, because the rising costs of health care make the growth potential near-inevitable.
-- Scott Barlow, Globe and Mail market strategist

<< Previous
Bullboard Posts
Next >>